Denise Dignam Acquires 3,378 Shares of Chemours (NYSE:CC) Stock

Posted by George Bondi on Aug 15th, 2026

The Chemours Company (NYSE:CC – Get Free Report) CEO Denise Dignam acquired 3,378 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average cost of $14.95 per share, with a total value of $50,501.10. Following the transaction, the chief executive officer owned 339,916 shares of the company’s stock, valued at approximately $5,081,744.20. The trade was a 1.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Chemours Stock Performance

Shares of CC opened at $15.81 on Friday. The Chemours Company has a 1 year low of $10.44 and a 1 year high of $28.67. The company’s 50 day simple moving average is $18.54 and its 200 day simple moving average is $20.00. The company has a market capitalization of $2.38 billion, a price-to-earnings ratio of -8.28 and a beta of 1.43. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.88 and a current ratio of 1.66.

Chemours (NYSE:CC – Get Free Report) last announced its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.07). The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.65 billion. Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The firm’s revenue was down 1.5% compared to the same quarter last year. During the same quarter last year, the business posted ($2.54) EPS. On average, sell-side analysts predict that The Chemours Company will post 0.88 EPS for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 14th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.2%. Chemours’s payout ratio is currently -18.32%.

Analyst Ratings Changes

CC has been the topic of several recent analyst reports. JPMorgan Chase & Co. reduced their target price on Chemours from $22.00 to $15.00 and set a “neutral” rating on the stock in a research report on Thursday. Truist Financial dropped their price objective on shares of Chemours from $30.00 to $24.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Weiss Ratings lowered shares of Chemours from a “sell (d)” rating to a “sell (d-)” rating in a report on Thursday, August 6th. The Goldman Sachs Group reissued a “neutral” rating and issued a $17.00 target price on shares of Chemours in a research report on Thursday. Finally, Zacks Research downgraded shares of Chemours from a “strong-buy” rating to a “strong sell” rating in a report on Tuesday. Five equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.10.

Get Our Latest Analysis on CC

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Atlas Capital Advisors Inc. acquired a new stake in Chemours during the fourth quarter worth about $26,000. Aster Capital Management DIFC Ltd purchased a new position in shares of Chemours in the 4th quarter worth about $28,000. Covestor Ltd lifted its stake in shares of Chemours by 204.7% in the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 1,748 shares in the last quarter. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Chemours during the 4th quarter worth about $31,000. Finally, Rothschild Investment LLC grew its holdings in shares of Chemours by 87.0% during the 4th quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares during the period. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours News Summary

Here are the key news stories impacting Chemours this week:

Positive Sentiment: Chemours is expanding its low-GWP Opteon refrigerant portfolio to address rising cooling demand from AI-driven data centers. The initiative could support growth in a higher-demand market while aligning with customers’ decarbonization goals. Zacks article on Chemours refrigerants for data centers
Positive Sentiment: CEO Denise Dignam bought 3,378 shares for approximately $50,500, while insider Gerardo Familiar Calderon purchased 1,935 shares for roughly $30,000. The open-market purchases may suggest that insiders view the recent share-price weakness as an opportunity. SEC filing on CEO purchase SEC filing on insider purchase
Neutral Sentiment: BMO Capital Markets cut its price target from $26 to $18 but maintained an “outperform” rating, leaving implied upside while signaling reduced expectations. The broader analyst consensus remains “hold,” with an average target near $20.10.
Negative Sentiment: A securities-fraud investigation involving Chemours was announced, creating a potential legal and reputational overhang for shareholders. The announcement does not establish wrongdoing, but it may increase uncertainty around the company.
Negative Sentiment: JPMorgan lowered its price target from $22 to $15 and kept a “neutral” rating, while Zacks Research downgraded the stock from “strong buy” to “strong sell.” These actions reinforce concerns following Chemours’ recent quarterly EPS and revenue misses. Benzinga report on JPMorgan target cut Zacks rating report

Chemours Company Profile

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.